Skip to main content
. Author manuscript; available in PMC: 2021 Jul 13.
Published in final edited form as: Nat Rev Cancer. 2021 Mar 17;21(5):313–324. doi: 10.1038/s41568-021-00340-6

Table 1.

Kinase selectivity of current clinical FAK inhibitors.

Compound IC50 values for in vitro kinase inhibition [nM] (assay type) # kinases with IC50 < 1 μM Reference
FAK PYK2
IN10018 (BI 853520) 1 (DELFIA)
38.1 (Z-LYTE)
>50,000 (DELFIA)
2000 (Z-LYTE)
4 48
Defactinib (VS-6063) (PF-04554878) 0.47 (Kinobeads)
0.6 (Kinase assay)
423 (Kinobeads)
0.6 (Kinase assay)
9 32,49